RxDoctor Payments Data

James Gaunt, DO

Otolaryngology · North Kansas City, MONPI 1245670637

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 94.8% of the total across 101 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 21 manufacturers, the largest accounting for just 21.2% — the pattern of someone who eats at a lot of different presentations.

$3,308in general payments, 2019–2025

Across 101 payments — averaging $32.75 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Intersect ENT, Inc.$702
  • Aerin Medical Inc.$698
  • Acclarent, Inc$449
  • Integra Lifesciences Corporation$276
  • Sanofi$181
  • Optinose US, Inc.$164
  • plus $838 from 15 others

What the payments were for

  • Food & beverage$3,13795%
  • Education$1715%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,308 in reported general payments places this provider in the 80th percentile of 210 otolaryngology providers in Missouri.

See all otolaryngology providers in Missouri

Medicare billing

Part B allowed, 2024
$100,055
Medicare patients
506
Services billed
1,459

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Ipratropium Bromide158$4,744
Azelastine Hcl45$1,683
Pilocarpine Hcl23$1,139
Neomycin-Polymyxin-HydrocortNeomycin/Polymyxin B/Hydrocort20$927
Fluticasone Propionate71$823
Mupirocin102$764
Ofloxacin27$608
Nystatin33$441
Levocetirizine Dihydrochloride46$396
Methylprednisolone58$369
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav39$367
Doxycycline Hyclate19$248
Omeprazole28$239
Cephalexin39$198
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen30$146

Paid to pharmacies, not to this prescriber.

Other otolaryngology in North Kansas City

See the full list for Missouri

Where these figures come from

Is this you, or does something look wrong? →